Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Summary
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study
Official title: A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Non-segmental Vitiligo
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-10-31
Completion Date
2027-08-30
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
VC005 tablets
VC005 groups repeat administration for 52 weeks
VC005 Tablets Placebo
VC005 Placebo groups repeat administration for 52 weeks
Locations (1)
The Peking University People's Hospital
Beijing, Beijng, China